# Establishing 18F PMPBB3 (APN 1607) PET Imaging Markers for Diagnosis of Tauopathy Parkinsonism Syndromes

> **NCT04557865** · NA · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 68 (actual)

## Conditions studied

- Tau Distributions in Patients With Tauopathy Using APN-1607 PET Scan

## Interventions

- **DIAGNOSTIC_TEST:** 18F-PMPBB3 (APN-1607) PET imaging

## Key facts

- **NCT ID:** NCT04557865
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-31
- **Primary completion:** 2024-09-02
- **Final completion:** 2024-09-02
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2024-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04557865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04557865, "Establishing 18F PMPBB3 (APN 1607) PET Imaging Markers for Diagnosis of Tauopathy Parkinsonism Syndromes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04557865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*